INTERNATIONAL PATENT: VENTUS THERAPEUTICS U.S., INC. FILES APPLICATION FOR "SOLID FREEBASE FORMS OF 5-CHLORO-2-(4-((2-HYDROXY-2- METHYLPROPYL)AMINO)PYRIDO[3,4-D[PYRIDAZIN-1-YL)PHENOL FOR INHIBITING NLRP3 AND USES THEREOF"

GENEVA, June 4 -- VENTUS THERAPEUTICS U.S., INC. (100 Beaver Street, Suite 201Waltham, Massachusetts 02453) filed a patent application (PCT/US2024/056526) for "SOLID FREEBASE FORMS OF 5-CHLORO-2-(4-((2-HYDROXY-2- METHYLPROPYL)AMINO)PYRIDO[3,4-D[PYRIDAZIN-1-YL)PHENOL FOR INHIBITING NLRP3 AND USES THEREOF" on Nov 19, 2024. With publication no. WO/2025/111267, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MURPHY, Luke J. (18 Stevens RoadDartmouth, Nova Scotia B2W 1P5)

Abstract: The present disclosure relates to solid st...